Moritz   Beissenhirtz

2023-07 - heute
Investment Director Life Sciences
Brandenburg Kapital GmbH

2022-02 - 2023-06
Project Manager Business Development
Sartorius

2019-10 - 2022-02
Manager Business Development
Thermo Fisher Scientific | Clinical Diagnostics Biomarkers (BRAHMS GmbH)

2016-08 - 2019-09
Director of Business Development and IP
Mologen AG

2009-12 - 2016-08
Head of IP Department
Mologen AG

2008-04 - 2009-11
Senior Patent Analyst
IP Bewertungs AG

2006-09 - 2008-03
Post Doc
iPOC - Universität Potsdam

2005-06 - 2006-08
PostDoc
Hebrew University of Jerusalem

2001-11 - 2005-06
Doktorand
Universität Potsdam / IMPRS

Patentreferent

Deutsch Muttersprache, Englisch Fließend